We presented preclinical data highlighting an innovative new class of mutant-targeted catalytic RAS(ON) inhibitors at the @AACR Annual Meeting.

Read more: https://t.co/Yh5N4Hlf6f

#AACR26 https://t.co/sIB4XhzB7e